Search

everythinglearnresearchcommunity

for

Search:↓

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

SLE and DM can coexist but are rare and need careful evaluation.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Psychosis can be an early sign of neuropsychiatric lupus, treatable with tailored medication.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

Early identification of lupus through skin signs and blood tests is crucial in India.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Visual field defects in lupus nephritis can be caused by hypertensive retinopathy, not glaucoma or medication toxicity.

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Hydroxychloroquine is ineffective for treating frontal fibrosing alopecia with lupus erythematosus.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

Hydroxychloroquine may help delay skin damage in lupus patients.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.